
|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Political Science
Concern that gene and stem-cell research could lead to human cloning has generated proposals for legislative bans, which could block promising research.
Advertisement
Articles in this issue
over 24 years ago
Policy: Task Mastersover 24 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearover 24 years ago
Friends of Complexityover 24 years ago
Under Federal Fireover 24 years ago
Task Force: Enter the Fixersover 24 years ago
The Next Y2KNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Eli Lilly’s Continuing GLP-1 Success
2
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
3
JP Morgan 2026: AbbVie Advances its Pipeline
4
JP Morgan 2026: Genmab Prioritizing Sustained Growth Over Next Decade
5




